LENZ Therapeutics, Inc.
LENZ
$4.73
$0.132.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.07% | -15.58% | -114.95% | -11.99% | -2.00% |
| Total Depreciation and Amortization | -0.90% | 3.74% | -14.40% | 557.89% | -47.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.72% | 35.20% | 21.45% | 53.45% | 16.63% |
| Change in Net Operating Assets | -432.92% | 771.57% | -109.50% | 224.57% | 154.97% |
| Cash from Operations | -15.28% | -1.69% | -284.55% | 25.37% | 28.29% |
| Capital Expenditure | 11.11% | 52.63% | 91.34% | -82.92% | -118.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.84% | 136.96% | -2,205.39% | -2,137.93% | -100.92% |
| Cash from Investing | 13.85% | 136.92% | -1,972.70% | -946.62% | -102.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,721.43% | -99.99% | 20,404.18% | -97.74% | 60,100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,721.43% | -99.99% | 20,404.18% | -97.74% | 60,100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.57% | -85.00% | 98.21% | -184.60% | 405.06% |